Biosynthema Inc.
Records under this name other than patents Biosynthema Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Biosynthema Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,293,873 | Combination of amino acid solution and a gelatin derivative for inhibiting renal up-take Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,122,622 | Peptide compounds having improved binding affinity to somatostatin receptors Formerly held Term ended Term ended Dec 26, 2023 · From the USPTO record | Term ended | Term ended Dec 26, 2023 | From the USPTO record |
| US 7,202,330 | RGD (Arg-Gly-Asp) coupled to (neuro)peptides Formerly held Term ended Term ended Dec 31, 2022 · From the USPTO record | Term ended | Term ended Dec 31, 2022 | From the USPTO record |
| US 6,664,367 | Stable analogs of bioactive peptides containing disulfide linkages Formerly held Term ended Term ended Dec 16, 2020 · From the USPTO record | Term ended | Term ended Dec 16, 2020 | From the USPTO record |
| US 7,015,306 | Labeled neurotensin derivatives Formerly held Lapsed on the fee record Ended Mar 21, 2018 · From the USPTO record | Lapsed on the fee record | Ended Mar 21, 2018 | From the USPTO record |
| US 5,310,536 | Ligands for improving metal chelate formation kinetics Formerly held Term ended Term ended no later than May 10, 2014 · Low confidence | Term ended | Term ended no later than May 10, 2014 | Low confidence |